Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)700-701
Number of pages2
JournalTransplantation and Cellular Therapy
Volume27
Issue number9
DOIs
StatePublished - Sep 2021

Bibliographical note

Funding Information:
J.H.Y. is a co-investigator for the Center for International Blood and Marrow Transplant Research study under ClinicalTrials.gov identifier NCT01166009. J.H.Y. reports that The University of Minnesota is paid on a per-subject basis to cover the costs of enrolling subjects on clinical trials unrelated to coronavirus infections, for AlloVir, Astellas, Ansun, Cidara, Janssen, Merck, NobelPharma, ReViral, Scynexis, and Shire/Takeda, outside the submitted work.

Cite this